EE200300487A - Peptiid-põhine immunoteraapia ateroskleroosi raviks ja peptiid-põhise määramise arendamine immuunvastuste määramiseks oksüdeeritud madala tihedusega lipoproteiini vastu - Google Patents

Peptiid-põhine immunoteraapia ateroskleroosi raviks ja peptiid-põhise määramise arendamine immuunvastuste määramiseks oksüdeeritud madala tihedusega lipoproteiini vastu

Info

Publication number: EE200300487A
Authority: EE; Estonia
Prior art keywords: peptide; atherosclerosis; development; treatment; low density
Prior art date: 2001-04-05

Application number

EEP200300487A

Other languages

English (en)

Estonian (et)

Inventor

Nilsson Jan

K. Shah Prediman

Original Assignee

Forskarpatent I Syd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-05

Filing date

2002-04-05

Publication date

2004-02-16

2001-04-05 Priority claimed from SE0101232A external-priority patent/SE0101232D0/xx

2002-04-05 Application filed by Forskarpatent I Syd filed Critical Forskarpatent I Syd

2002-04-05 Priority to EEP200700052A priority Critical patent/EE200700052A/xx

2004-02-16 Publication of EE200300487A publication Critical patent/EE200300487A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Marine Sciences & Fisheries (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)

EEP200300487A 2001-04-05 2002-04-05 Peptiid-põhine immunoteraapia ateroskleroosi raviks ja peptiid-põhise määramise arendamine immuunvastuste määramiseks oksüdeeritud madala tihedusega lipoproteiini vastu EE200300487A (et)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
EEP200700052A EE200700052A (et)	2001-04-05	2002-04-05	Antikeha he v?i mitme apo-lipoproteiin B fragmendi vastu

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0101232A SE0101232D0 (sv)	2001-04-05	2001-04-05	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein
SE0103754A SE0103754L (sv)	2001-04-05	2001-11-09	Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
PCT/SE2002/000679 WO2002080954A1 (en)	2001-04-05	2002-04-05	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein

Publications (1)

Publication Number	Publication Date
EE200300487A true EE200300487A (et)	2004-02-16

Family

ID=26655437

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
EEP200700052A EE200700052A (et)	2001-04-05	2002-04-05	Antikeha he v?i mitme apo-lipoproteiin B fragmendi vastu
EEP200300487A EE200300487A (et)	2001-04-05	2002-04-05	Peptiid-põhine immunoteraapia ateroskleroosi raviks ja peptiid-põhise määramise arendamine immuunvastuste määramiseks oksüdeeritud madala tihedusega lipoproteiini vastu

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
EEP200700052A EE200700052A (et)	2001-04-05	2002-04-05	Antikeha he v?i mitme apo-lipoproteiin B fragmendi vastu

Country Status (18)

Country	Link
EP (42)	EP2295458A1 (xx)
JP (6)	JP2004529143A (xx)
CN (4)	CN103122031B (xx)
AT (2)	ATE510851T1 (xx)
AU (1)	AU2002246484B8 (xx)
BR (1)	BR0208685A (xx)
CA (3)	CA2443223C (xx)
CY (1)	CY1108817T1 (xx)
DE (1)	DE60230029D1 (xx)
DK (3)	DK2295464T3 (xx)
EE (2)	EE200700052A (xx)
ES (2)	ES2546293T3 (xx)
IL (4)	IL158285A0 (xx)
PL (4)	PL217858B1 (xx)
PT (1)	PT1383526E (xx)
RU (1)	RU2296582C2 (xx)
SE (1)	SE0103754L (xx)
WO (1)	WO2002080954A1 (xx)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030105003A1 (en)	2001-04-05	2003-06-05	Jan Nilsson	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
SE0103754L (sv) *	2001-04-05	2002-10-06	Forskarpatent I Syd Ab	Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
AU2002362612B2 (en)	2001-09-28	2007-11-15	Cedars-Sinai Medical Center	Prevention and treatment of restenosis by local administration of drug
CA2500895A1 (en) *	2002-10-04	2004-04-15	Forskarpatent I Syd Ab	Peptide-based passive immunization therapy for treatment of atherosclerosis
SE0302312D0 (sv) *	2002-10-04	2003-08-27	Forskarpatent I Syd Ab	Peptide-based passive immunization therapy for treatment of atherosclerosis
SE0302422D0 (sv)	2003-09-11	2003-09-11	Forskarpatent I Syd Ab	Peptide-based immunization therapy for treatment of atherosclerosis
SE0400683D0 (sv) *	2004-03-19	2004-03-19	Forskarpatent I Syd Ab	Use of modified extracellular matrix proteins in diagnosis and treatment of a atherosclerosis
US8926958B2 (en)	2004-04-06	2015-01-06	Cedars-Sinai Medical Center	Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein A-I and apolipoprotein A-I milano
SI1735349T1 (sl)	2004-04-15	2010-12-31	Athera Biotechnologies Ab	Postopek ocenitve tveganja ishemske kardiovaskularne bolezni z uporabo fosforilholinskih konjugatov
EP1676602A1 (en) *	2005-01-04	2006-07-05	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis
GB0517878D0 (en)	2005-09-02	2005-10-12	Bioinvent Int Ab	Immunotherapeutic treatment
JP2010515023A (ja) *	2006-12-22	2010-05-06	アボット・ラボラトリーズ	心血管系自己免疫疾患パネルおよびその使用方法
WO2008104194A1 (en) *	2007-02-28	2008-09-04	Bioinvent International Ab	Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques
UA100684C2 (uk)	2007-03-15	2013-01-25	Новартіс Аг	Похідні бензилу та піридинілу як модулятори сигнального шляху hedgehog
CN108196072A (zh) *	2007-11-05	2018-06-22	北欧生物科技公司	用于进行cvd风险评估的生物化学标志物
US20100041663A1 (en)	2008-07-18	2010-02-18	Novartis Ag	Organic Compounds as Smo Inhibitors
JP5742002B2 (ja) *	2008-08-15	2015-07-01	藤倉化成株式会社	動脈硬化診断用ポリペプチドマーカー、及び該マーカー等を用いる動脈硬化の検出を補助する方法、並びに動脈硬化診断用キット
AU2010319323B2 (en)	2009-11-14	2015-01-15	Cardiovax, Llc	Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis
US8506964B2 (en) *	2010-02-05	2013-08-13	Cardiovax, Llc	Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
US20130142760A1 (en)	2010-08-18	2013-06-06	Cedars-Sinai Medical Center	Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer
US9205139B2 (en)	2010-11-12	2015-12-08	Cardiovax, Llc	Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
US20130302362A1 (en) *	2010-11-12	2013-11-14	Cedars-Sinai Medical Center	Immunomodulatory Compositions, Methods and Systems Comprising Immunogenic Fragments of ApoB-100
JP2014516913A (ja)	2010-11-12	2014-07-17	シーダースシナイメディカルセンター	高血圧の治療及び／又は予防のための免疫調節方法及びシステム
HRP20190988T1 (hr)	2011-08-09	2019-09-20	Athera Biotechnologies Ab	Nova protutijela protiv fosforilkolina
EP2741770A4 (en)	2011-08-09	2014-12-31	Athera Biotechnologies Ab	ANTIBODY BINDING TO PHOSPHORYLCHOLIN (PC) AND / OR PC CONJUGATES
RU2495048C1 (ru) *	2012-04-18	2013-10-10	Андрей Валентинович Исаев	Пептид, обладающий антиатеросклеротическим действием и композиция для профилактики и лечения атеросклероза сосудов
MX364626B (es) *	2012-11-06	2019-05-03	Les Hopitaux Univ De Geneve	Péptidos miméticos.
CN103520713B (zh) *	2013-10-16	2015-10-28	西北农林科技大学	一种ApoB100酵母重组疫苗及其制备方法和应用
CN103860470A (zh) *	2014-03-05	2014-06-18	贵州中泰生物科技有限公司	一种口服高密度脂蛋白脂质体的制备方法
CN105315364B (zh) *	2014-06-17	2018-09-18	广州文瑞生物科技有限公司	胶原蛋白vi疫苗预防动脉粥样硬化
CN108135973B (zh) *	2015-05-19	2021-10-19	拉·约拉过敏反应及免疫医学研究所	调节炎症应答及治疗不良心血管事件、病和粥样硬化的人apob100表位、方法和用途
US10858422B2 (en)	2016-05-31	2020-12-08	Abcentra, Llc	Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
CN108478817B (zh) *	2018-03-16	2020-10-27	北京大学	一种动脉粥样硬化检测试剂及其制备方法
KR20210044742A (ko)	2018-05-29	2021-04-23	앱센트라 엘엘시	건선 치료용 조성물 및 방법
WO2019232081A1 (en)	2018-05-29	2019-12-05	Abcentra, Llc	Compositions and methods for treatment of rheumatoid arthritis and accelerated atherosclerosis
CN115025210B (zh) *	2021-03-05	2025-09-05	香港中文大学	减少动脉粥样硬化进展的肽疫苗组合物和药物制剂
CN115025211A (zh) *	2021-11-02	2022-09-09	南京理工大学	用于动脉粥样硬化治疗的纳米疫苗及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4970144A (en)	1984-12-31	1990-11-13	International Genetic Engineering	Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
US5972890A (en) *	1988-05-02	1999-10-26	New England Deaconess Hospital Corporation	Synthetic peptides for arterial imaging
WO1993018067A1 (en) *	1992-03-06	1993-09-16	Abbott Laboratories	Immunocapture assay for direct quantitation of specific lipoprotein cholesterol levels
WO1994000592A1 (en) *	1992-06-26	1994-01-06	Exocell, Inc.	Monoclonal antibodies against glycated low density lipoprotein
EP0671926B1 (en) *	1992-08-11	2002-11-13	President And Fellows Of Harvard College	Immunomodulatory peptides
KR0185334B1 (ko)	1995-11-02	1999-04-01	김은영	인간 혈장 아포지단백질 비-100에 결합하는 생쥐 항체를 암호하는 씨디엔에이
GB9609702D0 (en) *	1996-05-09	1996-07-10	Royal Free Hosp School Med	Anticoagulant peptides
GB9620153D0 (en) *	1996-09-27	1996-11-13	Univ Strathclyde	Non-naturally occurring lipoprotein particle
GB9705831D0 (en) *	1997-03-20	1997-05-07	Univ Leicester	Oxidised ldl
US6635623B1 (en) *	1997-06-13	2003-10-21	Baylor College Of Medicine	Lipoproteins as nucleic acid vectors
US6225070B1 (en)	1997-08-07	2001-05-01	The Regents Of The University Of California	Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
US6156315A (en) *	1997-10-10	2000-12-05	The Trustees Of Columbia University In The City Of New York	Method for inhibiting the binding of low density lipoprotein to blood vessel matrix
US6309844B1 (en) *	1997-10-15	2001-10-30	Fujirebio Inc.	Anti-apo-B-48 monoclonal antibody, hybridoma producing the same, and method for measuring apo-B-48 using the same
CA2323056A1 (en) *	1998-03-10	1999-09-16	Regents Of The University Of California	Methods and tools for identifying compounds which modulate atherosclerosis by impacting ldl-proteoglycan binding
AU5200699A (en) *	1998-07-13	2000-02-01	University Of Otago	Inhibition of lipoprotein formation
IL126447A (en) *	1998-10-04	2004-09-27	Vascular Biogenics Ltd	An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
CA2389849A1 (en) *	1999-10-26	2001-05-10	Regents Of The University Of California	Reagents and methods for diagnosing, imaging and treating atherosclerotic disease
GB2373500B (en) *	2000-02-04	2004-12-15	Aeomica Inc	Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
ATE265860T1 (de) *	2000-03-03	2004-05-15	Glaxosmithkline Biolog Sa	Impstoff zur behandlung von atherosclerosis
SE0000855D0 (sv) *	2000-03-15	2000-03-15	Karolinska Innovations Ab	Antigenic composition useful as a vaccine against atherosclerosis
GB0017641D0 (en) *	2000-07-18	2000-09-06	Medigene Oy	Peptides and their use
EP1186299A1 (en) *	2000-09-12	2002-03-13	Universitair Medisch Centrum Utrecht	The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system
CA2425513A1 (en) *	2000-10-25	2002-06-20	Vincent Agnello	Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
WO2002042426A2 (en) *	2000-11-10	2002-05-30	University Of Utah Research Foundation	Carrier system for specific artery wall gene delivery
SE0103754L (sv) *	2001-04-05	2002-10-06	Forskarpatent I Syd Ab	Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
CN1312178C (zh) *	2001-05-15	2007-04-25	株式会社Jimro	高密度脂蛋白反应性肽
WO2003007689A2 (en) *	2001-07-20	2003-01-30	Eidgenoessische Technische Hochschule Zurich (Ethz)	Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids

2001
- 2001-11-09 SE SE0103754A patent/SE0103754L/xx not_active Application Discontinuation
2002
- 2002-04-05 EP EP10180099A patent/EP2295458A1/en not_active Withdrawn
- 2002-04-05 EP EP10180106A patent/EP2289912A1/en not_active Withdrawn
- 2002-04-05 EP EP10181267.5A patent/EP2295464B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10181196A patent/EP2289928A1/en not_active Withdrawn
- 2002-04-05 PL PL391615A patent/PL217858B1/pl unknown
- 2002-04-05 EP EP10180823A patent/EP2289919A1/en not_active Withdrawn
- 2002-04-05 EP EP10180838A patent/EP2289923A1/en not_active Withdrawn
- 2002-04-05 BR BR0208685-9A patent/BR0208685A/pt not_active Application Discontinuation
- 2002-04-05 EP EP10181173A patent/EP2289926A1/en not_active Withdrawn
- 2002-04-05 EP EP10180826A patent/EP2289920A1/en not_active Withdrawn
- 2002-04-05 EP EP10180172A patent/EP2289915A1/en not_active Withdrawn
- 2002-04-05 ES ES10181267.5T patent/ES2546293T3/es not_active Expired - Lifetime
- 2002-04-05 EP EP10180199A patent/EP2289918A1/en not_active Withdrawn
- 2002-04-05 PL PL400308A patent/PL400308A1/pl unknown
- 2002-04-05 PL PL385189A patent/PL215401B1/pl unknown
- 2002-04-05 EE EEP200700052A patent/EE200700052A/xx unknown
- 2002-04-05 EP EP10180184A patent/EP2295462A1/en not_active Withdrawn
- 2002-04-05 EP EP10180168A patent/EP2295461A1/en not_active Withdrawn
- 2002-04-05 WO PCT/SE2002/000679 patent/WO2002080954A1/en not_active Ceased
- 2002-04-05 IL IL15828502A patent/IL158285A0/xx unknown
- 2002-04-05 DK DK10181267.5T patent/DK2295464T3/en active
- 2002-04-05 EP EP08167532A patent/EP2147680A3/en not_active Withdrawn
- 2002-04-05 EP EP10180026A patent/EP2295457A1/en not_active Withdrawn
- 2002-04-05 CN CN201210322795.9A patent/CN103122031B/zh not_active Expired - Lifetime
- 2002-04-05 AT AT08151489T patent/ATE510851T1/de not_active IP Right Cessation
- 2002-04-05 EP EP10180193A patent/EP2289917A1/en not_active Withdrawn
- 2002-04-05 DK DK02714667T patent/DK1383526T3/da active
- 2002-04-05 EP EP10180845A patent/EP2289924A1/en not_active Withdrawn
- 2002-04-05 EP EP10180109A patent/EP2289913A1/en not_active Withdrawn
- 2002-04-05 EP EP10181263A patent/EP2295463A1/en not_active Withdrawn
- 2002-04-05 CN CNA2009100095655A patent/CN101486766A/zh active Pending
- 2002-04-05 RU RU2003132443/15A patent/RU2296582C2/ru active
- 2002-04-05 EE EEP200300487A patent/EE200300487A/xx unknown
- 2002-04-05 PL PL02367301A patent/PL367301A1/xx unknown
- 2002-04-05 PT PT02714667T patent/PT1383526E/pt unknown
- 2002-04-05 EP EP02714667A patent/EP1383526B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10181167A patent/EP2289925A1/en not_active Withdrawn
- 2002-04-05 EP EP10180188A patent/EP2289916A1/en not_active Withdrawn
- 2002-04-05 EP EP10180835A patent/EP2289922A1/en not_active Withdrawn
- 2002-04-05 EP EP10180176A patent/EP2305708A1/en not_active Withdrawn
- 2002-04-05 ES ES02714667T patent/ES2317999T3/es not_active Expired - Lifetime
- 2002-04-05 EP EP08167533A patent/EP2147930A3/en not_active Withdrawn
- 2002-04-05 EP EP10180115A patent/EP2305707A1/en not_active Withdrawn
- 2002-04-05 EP EP10180091A patent/EP2305706A1/en not_active Withdrawn
- 2002-04-05 EP EP10180156A patent/EP2295459A1/en not_active Withdrawn
- 2002-04-05 CA CA2443223A patent/CA2443223C/en not_active Expired - Lifetime
- 2002-04-05 EP EP10181245A patent/EP2289933A1/en not_active Withdrawn
- 2002-04-05 EP EP10181203A patent/EP2289929A1/en not_active Withdrawn
- 2002-04-05 EP EP10180828A patent/EP2289921A1/en not_active Withdrawn
- 2002-04-05 AT AT02714667T patent/ATE415423T1/de active
- 2002-04-05 CN CN028089405A patent/CN1505525B/zh not_active Expired - Fee Related
- 2002-04-05 EP EP07119130A patent/EP1918300A3/en not_active Withdrawn
- 2002-04-05 AU AU2002246484A patent/AU2002246484B8/en not_active Expired
- 2002-04-05 EP EP10180111A patent/EP2289914A1/en not_active Withdrawn
- 2002-04-05 EP EP10181213A patent/EP2289930A1/en not_active Withdrawn
- 2002-04-05 EP EP10181253.5A patent/EP2289934B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10181188A patent/EP2289927A1/en not_active Withdrawn
- 2002-04-05 DK DK08151489.5T patent/DK2006301T3/da active
- 2002-04-05 EP EP10181273A patent/EP2289935A1/en not_active Withdrawn
- 2002-04-05 DE DE60230029T patent/DE60230029D1/de not_active Expired - Lifetime
- 2002-04-05 JP JP2002578993A patent/JP2004529143A/ja not_active Withdrawn
- 2002-04-05 EP EP10181227A patent/EP2289932A1/en not_active Withdrawn
- 2002-04-05 EP EP10180162.9A patent/EP2295460B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10181217A patent/EP2289931A1/en not_active Withdrawn
- 2002-04-05 CN CN2007101953989A patent/CN101284874B/zh not_active Expired - Lifetime
- 2002-04-05 EP EP08151489A patent/EP2006301B1/en not_active Expired - Lifetime
- 2002-04-05 CA CA2827167A patent/CA2827167A1/en not_active Abandoned
- 2002-04-05 CA CA2606839A patent/CA2606839C/en not_active Expired - Lifetime
- 2002-04-05 EP EP08158141A patent/EP2147928A3/en not_active Withdrawn
- 2002-04-05 EP EP08167531A patent/EP2147929A3/en not_active Ceased
2003
- 2003-10-07 IL IL158285A patent/IL158285A/en active IP Right Grant
2007
- 2007-12-20 IL IL188286A patent/IL188286A0/en unknown
2008
- 2008-01-25 JP JP2008015545A patent/JP2008169215A/ja not_active Withdrawn
- 2008-11-18 IL IL195356A patent/IL195356A0/en unknown
2009
- 2009-02-24 CY CY20091100202T patent/CY1108817T1/el unknown
- 2009-06-02 JP JP2009133383A patent/JP5270456B2/ja not_active Expired - Fee Related
2010
- 2010-10-26 JP JP2010239478A patent/JP5300820B2/ja not_active Expired - Lifetime
- 2010-10-26 JP JP2010239477A patent/JP5300819B2/ja not_active Expired - Lifetime
2013
- 2013-02-25 JP JP2013034312A patent/JP5613890B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
BR0208685A (pt)	2004-03-30
EP2289929A1 (en)	2011-03-02
PL400308A1 (pl)	2012-12-17
EP2295457A1 (en)	2011-03-16
ATE510851T1 (de)	2011-06-15
EP2295464A1 (en)	2011-03-16
PT1383526E (pt)	2009-02-27
JP2011063598A (ja)	2011-03-31
EP2289914A1 (en)	2011-03-02
JP2008169215A (ja)	2008-07-24
SE0103754D0 (sv)	2001-11-09
EP2289930A1 (en)	2011-03-02
CN1505525A (zh)	2004-06-16
CN103122031A (zh)	2013-05-29
CA2827167A1 (en)	2002-10-17
EP2289926A1 (en)	2011-03-02
EP2289919A1 (en)	2011-03-02
ES2546293T3 (es)	2015-09-22
EP2147928A2 (en)	2010-01-27
EP2289923A1 (en)	2011-03-02
IL195356A0 (en)	2009-08-03
AU2002246484A1 (en)	2002-10-21
EP2289917A1 (en)	2011-03-02
EP2289925A1 (en)	2011-03-02
EP2295460A1 (en)	2011-03-16
EP2289916A1 (en)	2011-03-02
EP2289915A1 (en)	2011-03-02
EP2295464B1 (en)	2015-06-03
IL188286A0 (en)	2008-03-20
EP2147929A2 (en)	2010-01-27
EP2289931A1 (en)	2011-03-02
EP2147930A3 (en)	2010-04-14
EP1918300A3 (en)	2009-06-17
EP2305706A1 (en)	2011-04-06
ATE415423T1 (de)	2008-12-15
EP2147680A3 (en)	2010-04-14
EP2147680A2 (en)	2010-01-27
JP2011068654A (ja)	2011-04-07
EE200700052A (et)	2008-08-15
JP2013144687A (ja)	2013-07-25
CN101284874A (zh)	2008-10-15
EP2289918A1 (en)	2011-03-02
AU2002246484B8 (en)	2007-06-14
PL367301A1 (en)	2005-02-21
CN103122031B (zh)	2015-07-22
CA2443223C (en)	2013-11-26
EP2295463A1 (en)	2011-03-16
JP2009191078A (ja)	2009-08-27
AU2002246484B2 (en)	2007-04-19
EP2289927A1 (en)	2011-03-02
EP2289932A1 (en)	2011-03-02
EP2289921A1 (en)	2011-03-02
EP2289928A1 (en)	2011-03-02
EP2289935A1 (en)	2011-03-02
CA2606839A1 (en)	2002-10-17
CN101284874B (zh)	2012-10-03
RU2003132443A (ru)	2005-02-27
EP2147930A2 (en)	2010-01-27
SE0103754L (sv)	2002-10-06
JP2004529143A (ja)	2004-09-24
CN101486766A (zh)	2009-07-22
CY1108817T1 (el)	2014-04-09
EP2295462A1 (en)	2011-03-16
EP2295458A1 (en)	2011-03-16
DE60230029D1 (de)	2009-01-08
EP2147929A3 (en)	2010-04-14
CN1505525B (zh)	2012-11-07
EP2295461A1 (en)	2011-03-16
RU2296582C2 (ru)	2007-04-10
PL215401B1 (pl)	2013-12-31
EP2289922A1 (en)	2011-03-02
EP2295459A1 (en)	2011-03-16
EP2289933A1 (en)	2011-03-02
CA2443223A1 (en)	2002-10-17
IL158285A0 (en)	2004-05-12
DK1383526T3 (da)	2009-03-30
IL158285A (en)	2009-12-24
EP2289920A1 (en)	2011-03-02
JP5300820B2 (ja)	2013-09-25
EP2289934B1 (en)	2013-11-13
EP2006301A1 (en)	2008-12-24
JP5300819B2 (ja)	2013-09-25
EP2289924A1 (en)	2011-03-02
EP1383526B1 (en)	2008-11-26
EP2289913A1 (en)	2011-03-02
JP5613890B2 (ja)	2014-10-29
WO2002080954A1 (en)	2002-10-17
PL217858B1 (pl)	2014-08-29
EP2295460B1 (en)	2015-06-03
EP2289934A1 (en)	2011-03-02
EP1918300A2 (en)	2008-05-07
EP1383526A1 (en)	2004-01-28
EP2289912A1 (en)	2011-03-02
EP2305708A1 (en)	2011-04-06
DK2006301T3 (da)	2011-09-12
EP2006301B1 (en)	2011-05-25
EP2305707A1 (en)	2011-04-06
CA2606839C (en)	2015-06-09
EP2147928A3 (en)	2010-04-14
ES2317999T3 (es)	2009-05-01
DK2295464T3 (en)	2015-08-17
JP5270456B2 (ja)	2013-08-21

Publication	Publication Date	Title
EE200300487A (et)	2004-02-16	Peptiid-põhine immunoteraapia ateroskleroosi raviks ja peptiid-põhise määramise arendamine immuunvastuste määramiseks oksüdeeritud madala tihedusega lipoproteiini vastu
DK296087D0 (da)	1987-06-10	Peptidmateriale og fremgangsmaade til paavisning af antistoffer til htlv-iii
ECSP024409A (es)	2003-02-06	Anticuerpos de especificidad doble y metodos para la elaboracion y el uso de los mismos
AT500379B8 (de)	2009-08-15	Tau-proteine
ATE373016T1 (de)	2007-09-15	Induktion von immunologischer toleranz gegen einen therapeutischen antikörper durch varianten des therapeutischen antikörpers
DE60331677D1 (de)	2010-04-22	Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
DK2133100T3 (da)	2012-01-23	MTB32A-Antigen af Mycobacterium tuberculosis med inaktiveret aktivt sted og fusionsproteiner deraf
PT1644484E (pt)	2008-10-21	Células autólogas de indução de auto-tolerância de origem monocítica e sua utilização em preparações farmacêuticas
ATE312909T1 (de)	2005-12-15	Diagnostika und behandlungen von peridontalen erkrankungen
EE200500012A (et)	2005-08-15	Peptiid-pähine passiivne immunoteraapia ateroskleroosi raviks
CY1106349T1 (el)	2011-10-12	Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
Sánchez et al.	2003	Epitopes of calreticulin recognised by IgA autoantibodies from patients with hepatic and coeliac disease
DK1682578T3 (da)	2008-10-27	Peptid-baseret immunoterapi til behandling af åreforkalkning
ATE500273T1 (de)	2011-03-15	Methoden zur analyse von antikörperdisulfidisomere
BRPI0216033B8 (pt)	2021-05-25	"terapia de imunização à base de peptídio para tratamento de arteriosclerose"
WO2002023202A8 (en)	2002-07-04	Method to identify antibody targets based on mass spectrometry (maldi-tof)
BRPI0204599B8 (pt)	2021-07-27	kit para a detecção simultânea de anticorpo para hcv e antígeno de hcv
SE0104354D0 (sv)	2001-12-21	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based ELISA for determination of immune responses against oxidized low-density lipoprotein

Legal Events

Date	Code	Title	Description
2004-04-15	HB1A	Correction of owner name or address